BioAge Labs, Inc. (BIOA)
NASDAQ: BIOA · Real-Time Price · USD
3.820
-0.060 (-1.55%)
At close: Mar 28, 2025, 4:00 PM
3.915
+0.095 (2.49%)
After-hours: Mar 28, 2025, 7:50 PM EDT

BioAge Labs Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022
Period Ending
Dec '24 Dec '23 Dec '22
Selling, General & Admin
19.1614.519.45
Research & Development
59.0433.8930.52
Operating Expenses
78.1948.439.97
Operating Income
-78.19-48.4-39.97
Interest Expense
-2.37-7.79-0.24
Interest & Investment Income
9.632.430.47
EBT Excluding Unusual Items
-70.93-53.76-39.75
Other Unusual Items
-0.18-10.090.02
Pretax Income
-71.11-63.85-39.72
Net Income
-71.11-63.85-39.72
Net Income to Common
-71.11-63.85-39.72
Shares Outstanding (Basic)
1122
Shares Outstanding (Diluted)
1122
Shares Change (YoY)
541.23%0.06%-
EPS (Basic)
-6.63-38.17-23.76
EPS (Diluted)
-6.63-38.17-23.76
Free Cash Flow
-51.89-37.53-36.28
Free Cash Flow Per Share
-4.84-22.43-21.70
EBITDA
-78.03-48.24-39.84
D&A For EBITDA
0.170.160.13
EBIT
-78.19-48.4-39.97
Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q